GRIFOLS | GRF - Sales Revenues


GRIFOLS reported EUR1.87B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Alcon AG USD 2.78B 90M Jun/2026
Almirall EUR 602.71M 55.09M Jun/2026
Amadeus IT EUR 1.65B 30M Jun/2026
Amarin USD 49.22M 451K Dec/2025
argenx SE USD 1.72B 361M Sep/2026
AstraZeneca USD 15.38B 90M Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Cie Automotive EUR 1.05B 908.2M Mar/2026
Demant DKK 6.67B 420M Jun/2026
Ence Energia y Celulosa EUR 153.9M 33.25M Mar/2026
Essilor EUR 14.82B 351M Jun/2026
Ferrovial EUR 2.6B 113M Jun/2026
Fresenius EUR 5.95B 210M Jun/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Genmab DKK 1.16B 259M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
GRIFOLS EUR 1.87B 170M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Inditex EUR 11B 2.26B Jun/2026
Lakefront Biotherapeutics EUR 12.11M 5.61M Jun/2026
Merck EUR 5.43B 300M Jun/2026
Novartis USD 14.52B 112M Sep/2026
Philips EUR 4.36B 450M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sanofi EUR 11.95B 710M Jun/2026
Smith & Nephew USD 1.6B 1.58B Jun/2026
UCB EUR 4.25B 764M Dec/2025
Viscofan EUR 336M 11M Sep/2026